{"classes":[{"categories":[{"measurements":[{"groupId":"OG000","lowerLimit":"1.4","upperLimit":"34.7","value":"11.1"},{"groupId":"OG001","lowerLimit":"20.8","upperLimit":"38.9","value":"29.2"}]}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"18"},{"groupId":"OG001","value":"106"}],"units":"Participants"}],"description":"Overall response defined as percentage of participants who achieved stringent complete response (sCR), complete response (CR), very good partial response (VGPR) or partial response (PR). Per IMWG criteria, sCR: is defined as normal free light chain (FLC) ratio, and absence of clonal plasma cells (PCs) by immunohistochemistry, immunofluorescence or 2- to 4-color flow cytometry; CR: Negative immunofixation on the serum and urine and disappearance of any soft tissue plasmacytomas and \\< 5 % plasma cells in bone marrow; VGPR: Serum and urine M-protein detectable by immunofixation but not on electrophoresis or \\>= 90% reduction in serum M-protein plus urine M-protein level \\< 100mg/24 hours; PR: \\>= 50 % reduction of serum M-protein and reduction in 24 hour urinary M-protein by \\>= 90% or to \\<200 mg/24 hours; if the serum and urine M-protein are not measurable, a decrease of \\>=50% in the difference between involved and uninvolved FLC levels is required in place of the M-protein criteria.","dispersionType":"95% Confidence Interval","groups":[{"description":"Daratumumab 8 milligram per kilogram (mg/kg) every 4 weeks (Q4W) until disease progression or unacceptable toxicity.","id":"OG000","title":"Daratumumab 8 mg/kg"},{"description":"Daratumumab 16 mg/kg weekly for 8 weeks; then every 2 weeks (Q2W) for 16 weeks; then Q4W until disease progression or unacceptable toxicity.","id":"OG001","title":"Daratumumab 16 mg/kg"}],"paramType":"NUMBER","populationDescription":"All treated analysis set included all participants who received at least 1 dose of daratumumab.","reportingStatus":"POSTED","timeFrame":"Up to 14.4 Months","title":"Percentage of Participants With Overall Response","type":"PRIMARY","unitOfMeasure":"percentage of participants"}